Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice
about
Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitroA review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges aheadEfficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A virusesModel-based simulation and prediction of an antiviral strategy against influenza A infection.Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.Continuing challenges in influenza.Antiviral therapy in seasonal influenza and 2009 H1N1 pandemic influenza: Korean experiences and perspectives.Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.INFLUENZA SURVEILLANCE IN RUSSIA BASED ON EPIDEMIOLOGICAL AND LABORATORY DATA FOR THE PERIOD FROM 2005 TO 2012.How I treat influenza in patients with hematologic malignancies.Combinations of L-NG-monomethyl-arginine and oseltamivir against pandemic influenza A virus infections in mice.Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia.ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION.Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.Combination chemotherapy for influenza.Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.Newer influenza antivirals, biotherapeutics and combinations.Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.In vitro system for modeling influenza A virus resistance under drug pressureCombinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.Effect of half-life on the pharmacodynamic index of zanamivir against influenza virus delineated by a mathematical modelTreatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.Exacerbation of influenza virus infections in mice by intranasal treatments and implications for evaluation of antiviral drugsEfficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective studySevere influenza treatment guideline.Influenza pharmacotherapy: present situation, strategies and hopes.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.Comparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studies.Combinations of 1,8-cineol and oseltamivir for the treatment of influenza virus A (H3N2) infection in mice.Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.Emerging influenza antiviral resistance threats.Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase.Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapiesInvestigating Different Mechanisms of Action in Combination Therapy for Influenza
P2860
Q21142648-8FB0013A-92DD-4319-B068-D7CC9DB94334Q28382972-DC4583C9-1BF0-47B4-A8C3-FC5645045CCAQ28479036-F855DF28-E92C-4F09-8FA2-5B1ECF5E687FQ30352246-6C7FE4AE-885A-427C-81F8-E84EF4D4EF75Q30359363-A829B626-0987-4988-A2F4-E7F5D2AA9C85Q30363190-01094E29-1846-448F-B4B6-DEBCE2E56365Q30377702-B1285447-7E95-45C3-A159-2C2EB20C2354Q30379095-58175176-E7FE-4447-B0E2-3A69D117EB5CQ30381281-5412B3D8-D9A8-491D-8221-477F1B79FB09Q30383456-4E904A29-647E-42D6-B536-07065AE15862Q30401138-407A4B97-9F63-4DD8-9B4A-A95810F25A82Q30403968-5E913F00-5854-4640-B72F-6E3C10C28FE0Q30404586-9F3F0E2F-C14E-4754-9905-61A83FBFFA31Q30407719-9E77FA00-80BA-42DD-B116-3CCEC5388505Q30408112-4BDAD0B4-AFB9-45A1-9245-74F42CEC8E4EQ30414428-87F69570-3A4D-4489-A00A-023BE43335F3Q30456363-1832CFB4-76C7-4A1E-B7DE-F64121DBF415Q33559151-4A31E765-FF32-48B0-B928-8BA4852DD05BQ34045479-3AD877E1-BBA0-4352-9716-6E001B1005BCQ34159076-E6D83A90-A1EE-4BD4-9144-81AB3D932531Q34737693-090F8A8A-79A1-492A-891D-0E4463077F43Q36301052-83424F52-8EF6-4659-A41A-771FBBAB4442Q36396088-74A83284-4945-446C-9EEB-C770930FCBF9Q36566014-55A4C7C3-9B0B-4A69-8009-EB57ABEA5931Q37598807-2065AA66-B639-414F-AF76-D7EDAB7CBBA7Q37857854-2089F854-1FB0-474F-91EF-8F31D63FD2D6Q38084212-0A076C32-471A-47F0-9FFE-133ECAF6DAFAQ38694084-01488D19-718D-4D0C-B144-D367CB6ED75BQ39102455-C1A7D8DA-D323-41C2-A04C-82254E22F96FQ40622883-A998F472-5191-495B-890E-09EBC8DA5A9EQ41928469-C7FA47A1-0A3B-4ED1-9BC6-4AE7D8BE1EA7Q42725866-365DF55C-30FC-4AC4-A72B-03194C301FBCQ45369417-06F43577-8C8C-45C2-A5E5-D68D46B19D09Q57930420-E888978D-373B-4DD1-979B-95BBA1DAF138Q58573517-67AAF96C-3478-4F97-BB0E-09C3719D9010
P2860
Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of double combinations ...... ns in cell culture and in mice
@en
Effects of double combinations ...... s in cell culture and in mice.
@nl
type
label
Effects of double combinations ...... ns in cell culture and in mice
@en
Effects of double combinations ...... s in cell culture and in mice.
@nl
prefLabel
Effects of double combinations ...... ns in cell culture and in mice
@en
Effects of double combinations ...... s in cell culture and in mice.
@nl
P2093
P2860
P356
P1476
Effects of double combinations ...... ns in cell culture and in mice
@en
P2093
Brett L Hurst
Kevin W Bailey
Min-Hui Wong
P2860
P304
P356
10.1128/AAC.01012-08
P407
P577
2009-03-09T00:00:00Z